Featured Article: Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody-Drug Conjugates (ADCs) are composed of an engineered antibody that has been chemically linked to a cytotoxic drug to form a single molecular structure. This combination of antigen specificity and potent cytotoxicity has caused ADCs to be an emerging topic in the field of cancer therapeutics.
In this review, C. Chalouni and S. Doll discuss the mechanisms involved that enable ADCs to trigger the death of tumor cells and how they can be potentially used in future therapeutic strategies for cancer.
Click here to access the full article.
Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.
Aims and scope
Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.
Please click here to read more.
Meeting reports now accepted
Mauro Castelli, Regina Elena National Cancer Institute, Italy
If you would like to contact Journal of Experimental & Clinical Cancer Research, please send an email to:
Call for papers: Translational oncology
We are pleased to announce that a number of BioMed Central journals have come together to create a new cross-journal series on translational oncology.
Guest Edited by Prof Tommaso Dragani (Fondazione IRCCS Istituto Nazionale dei Tumori, Italy), the series is now accepting submissions of research articles that provide important developments in cancer research. Preclinical studies should provide a significant advance in knowledge, and have clear potential for strong clinical impact. For more information on the series, please click here to visit the series page.
Journal of Experimental & Clinical Cancer Research has been publishing since 1982. Prior to publishing with BioMed Central from 2008, Journal of Experimental & Clinical Cancer Research was published in print. For enquiries about previous content, please contact us on:
The editorial team of Journal of Experimental & Clinical Cancer Research would like to thank all of our reviewers who have contributed to the journal.
Click here to visit the Reviewer acknowledgements page.
Owned by the Association for International Promotion & Study in Tumors (APSIT)
Official journal of the Regina Elena National Cancer Institute, Italy
- Editorial Board
- Sign up for article alerts and news from this journal
2016 Journal Metrics
8 days from submission to first decision
11 days from acceptance to publication
790.0 Usage Factor
Social Media Impact